400-920-2911 sales@csnpharm.cn
CAS No.: 1039455-84-9
COTI-2 is an orally available thiosemicarbazone and mutant p53 activator with potential antineoplastic activity.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02433626 | Ovarian Cancer ... more >> Fallopian Tube Cancer Endometrial Cancer Cervical Cancer Peritoneal Cancer Head and Neck Cancer HNSCC Collapse << | Phase 1 | Recruiting | December 2018 | United States, Illinois ... more >> Northwestern Memorial Hospital Recruiting Chicago, Illinois, United States Contact: Wilberto Nieves-Neira, MD 312-472-4684 Principal Investigator: Wilberto Nieves-Neira, MD United States, Texas MD Anderson Cancer Centre Recruiting Houston, Texas, United States Contact: Shannon Westin, MD 713-794-4314 Principal Investigator: Shannon Westin, MD Collapse << |
实验方案
技术信息
CAS号 | 1039455-84-9 | 储存条件 |
|
|||||
分子式 | C19H22N6S | 运输 | 蓝冰 | |||||
分子量 | 366.48 | 别名 | ||||||
溶解度 |
|
动物实验配方 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT02433626 | Ovarian Cancer ... more >> Fallopian Tube Cancer Endometrial Cancer Cervical Cancer Peritoneal Cancer Head and Neck Cancer HNSCC Collapse << | Phase 1 | Recruiting | December 2018 | United States, Illinois ... more >> Northwestern Memorial Hospital Recruiting Chicago, Illinois, United States Contact: Wilberto Nieves-Neira, MD 312-472-4684 Principal Investigator: Wilberto Nieves-Neira, MD United States, Texas MD Anderson Cancer Centre Recruiting Houston, Texas, United States Contact: Shannon Westin, MD 713-794-4314 Principal Investigator: Shannon Westin, MD Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网